COVAXIN phase-3 results show interim efficacy of 81%: Bharat Biotech releases data

Bharat Biotech announced the phase 3 results of its coronavirus vaccine ‘Covaxin’on Wednesday claiming the shots have demonstrated an interim clinical efficacy of nearly 81 per cent.

from Zee News :India National https://ift.tt/3kFHuMa